Funder
European Union: Horizon 2020 Research and Innovation Programme
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Bioengineering,Biotechnology
Reference42 articles.
1. Walther J, Godawat R, Hwang C, Abe Y, Sinclair A, Konstantinov K (2015) The business impact of an integrated continuous biomanufacturing platform for recombinant protein production. J Biotechnol 213:3–12
2. Farid SS (2007) Process economics of industrial monoclonal antibody manufacture. J Chromatogr B 848(1):8–18
3. Kelley B (2009) Industrialization of mAb production technology: the bioprocessing industry at a crossroads. mAbs, vol 1. Taylor & Francis, Abingdon, pp 443–452
4. Beck A, Reichert JM (2013) Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry. mAbs, vol 5. Taylor & Francis, Abingdon, pp 621–623
5. Yoo DH (2014) The rise of biosimilars: potential benefits and drawbacks in rheumatoid arthritis. Expert Revi Clin Immunol 10(8):981–983.
https://doi.org/10.1586/1744666X.2014.932690
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献